
Jeffrey H. Murray
Examiner (ID: 2022, Phone: (571)272-9023 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1699, 1609 |
| Total Applications | 1761 |
| Issued Applications | 1272 |
| Pending Applications | 9 |
| Abandoned Applications | 485 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10437057
[patent_doc_number] => 20150322070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'PIPERIDINE INHIBITORS OF JANUS KINASE 3'
[patent_app_type] => utility
[patent_app_number] => 14/596784
[patent_app_country] => US
[patent_app_date] => 2015-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23215
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14596784
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/596784 | Piperidine inhibitors of Janus kinase 3 | Jan 13, 2015 | Issued |
Array
(
[id] => 10241508
[patent_doc_number] => 20150126502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'INHIBITORS OF POLO-LIKE KINASE'
[patent_app_type] => utility
[patent_app_number] => 14/596824
[patent_app_country] => US
[patent_app_date] => 2015-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61128
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14596824
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/596824 | INHIBITORS OF POLO-LIKE KINASE | Jan 13, 2015 | |
Array
(
[id] => 10567349
[patent_doc_number] => 09290506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-22
[patent_title] => 'Processes for preparing JAK inhibitors and related intermediate compounds'
[patent_app_type] => utility
[patent_app_number] => 14/593688
[patent_app_country] => US
[patent_app_date] => 2015-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70786
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14593688
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/593688 | Processes for preparing JAK inhibitors and related intermediate compounds | Jan 8, 2015 | Issued |
Array
(
[id] => 10468542
[patent_doc_number] => 20150353557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'TYROSINE KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/590851
[patent_app_country] => US
[patent_app_date] => 2015-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75296
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14590851
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/590851 | TYROSINE KINASE INHIBITORS | Jan 5, 2015 | Abandoned |
Array
(
[id] => 10468539
[patent_doc_number] => 20150353556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'ORGANIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/589602
[patent_app_country] => US
[patent_app_date] => 2015-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27605
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589602
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/589602 | ORGANIC COMPOUNDS | Jan 4, 2015 | Abandoned |
Array
(
[id] => 10305378
[patent_doc_number] => 20150190379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'BAX-Activating Cancer Therapeutics'
[patent_app_type] => utility
[patent_app_number] => 14/589050
[patent_app_country] => US
[patent_app_date] => 2015-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13735
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589050
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/589050 | BAX-activating cancer therapeutics | Jan 4, 2015 | Issued |
Array
(
[id] => 10312524
[patent_doc_number] => 20150197526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'SELECTIVE EFFLUX INHIBITORS AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/587925
[patent_app_country] => US
[patent_app_date] => 2014-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 32609
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14587925
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/587925 | SELECTIVE EFFLUX INHIBITORS AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT | Dec 30, 2014 | Abandoned |
Array
(
[id] => 10614845
[patent_doc_number] => 09334280
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-10
[patent_title] => 'Synthetic rigidin analogues as anticancer agents, salts, solvates and prodrugs thereof, and method of producing same'
[patent_app_type] => utility
[patent_app_number] => 14/584929
[patent_app_country] => US
[patent_app_date] => 2014-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10876
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14584929
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/584929 | Synthetic rigidin analogues as anticancer agents, salts, solvates and prodrugs thereof, and method of producing same | Dec 28, 2014 | Issued |
Array
(
[id] => 12109337
[patent_doc_number] => 09865826
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-09
[patent_title] => 'Organometallic compound and organic light-emitting device including the same'
[patent_app_type] => utility
[patent_app_number] => 14/579499
[patent_app_country] => US
[patent_app_date] => 2014-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23544
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14579499
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/579499 | Organometallic compound and organic light-emitting device including the same | Dec 21, 2014 | Issued |
Array
(
[id] => 11121962
[patent_doc_number] => 20160318936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'PYRIMIDOPYRIMIDINONES USEFUL AS WEE-1 KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/105869
[patent_app_country] => US
[patent_app_date] => 2014-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92966
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105869
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/105869 | Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors | Dec 18, 2014 | Issued |
Array
(
[id] => 10209329
[patent_doc_number] => 20150094320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'PROCESSES FOR THE PREPARATION OF DIPYRIDAMOLE'
[patent_app_type] => utility
[patent_app_number] => 14/574652
[patent_app_country] => US
[patent_app_date] => 2014-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6034
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14574652
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/574652 | Processes for the preparation of dipyridamole | Dec 17, 2014 | Issued |
Array
(
[id] => 10281551
[patent_doc_number] => 20150166547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 14/571186
[patent_app_country] => US
[patent_app_date] => 2014-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63126
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14571186
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/571186 | Compounds and methods for kinase modulation, and indications therefor | Dec 14, 2014 | Issued |
Array
(
[id] => 11121905
[patent_doc_number] => 20160318878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'METHODS TO TREAT LYMPHOPLASMACYTIC LYMPHOMA'
[patent_app_type] => utility
[patent_app_number] => 15/104132
[patent_app_country] => US
[patent_app_date] => 2014-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 60046
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104132
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/104132 | Methods to treat lymphoplasmacytic lymphoma | Dec 11, 2014 | Issued |
Array
(
[id] => 10587650
[patent_doc_number] => 09309252
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Pyrrolopyrimidine compounds as inhibitors of CDK4/6'
[patent_app_type] => utility
[patent_app_number] => 14/568410
[patent_app_country] => US
[patent_app_date] => 2014-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82912
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14568410
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/568410 | Pyrrolopyrimidine compounds as inhibitors of CDK4/6 | Dec 11, 2014 | Issued |
Array
(
[id] => 11364028
[patent_doc_number] => 20170002009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'CRYSTALLINE FORM I OF IBRUTINIB'
[patent_app_type] => utility
[patent_app_number] => 15/100247
[patent_app_country] => US
[patent_app_date] => 2014-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3157
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15100247
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/100247 | Crystalline form I of ibrutinib | Nov 25, 2014 | Issued |
Array
(
[id] => 11602440
[patent_doc_number] => 20170119740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'Methods for Treating Cancer by Activation of BMP Signaling'
[patent_app_type] => utility
[patent_app_number] => 15/147719
[patent_app_country] => US
[patent_app_date] => 2014-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22511
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15147719
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/147719 | Methods for treating cancer by activation of BMP signaling | Nov 12, 2014 | Issued |
Array
(
[id] => 11100803
[patent_doc_number] => 20160297773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'PROCESSES FOR THE PREPARATION OF PYRIMIDINYLCYCLOPENTANE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/036741
[patent_app_country] => US
[patent_app_date] => 2014-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20750
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 66
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036741
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/036741 | Processes for the preparation of pyrimidinylcyclopentane compounds | Nov 12, 2014 | Issued |
Array
(
[id] => 11083744
[patent_doc_number] => 20160280710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'PROCESS FOR CRYSTALLINE PEMETREXED DIPOTASSIUM SALT'
[patent_app_type] => utility
[patent_app_number] => 15/036819
[patent_app_country] => US
[patent_app_date] => 2014-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4628
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036819
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/036819 | Process for crystalline pemetrexed dipotassium salt | Nov 10, 2014 | Issued |
Array
(
[id] => 10502817
[patent_doc_number] => 09231220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-05
[patent_title] => 'Substituted tetraarylbenzenes'
[patent_app_type] => utility
[patent_app_number] => 14/528582
[patent_app_country] => US
[patent_app_date] => 2014-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16264
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14528582
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/528582 | Substituted tetraarylbenzenes | Oct 29, 2014 | Issued |
Array
(
[id] => 11075653
[patent_doc_number] => 20160272618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'PHOTOCLEAVABLE CHEMICAL INDUCERS OF DIMERIZATION (CID) AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/031628
[patent_app_country] => US
[patent_app_date] => 2014-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10954
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15031628
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/031628 | Photocleavable chemical inducers of dimerization (CID) and methods of use | Oct 23, 2014 | Issued |